This inventor holds 1 USPTO granted patent and 1 published patent application, plus 1 CIPO patent. Top assignee: Centre National De La Recherche Scientifique. Active years: 1993.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1993
Title: Jean Costentin: Innovator in Pharmaceutical Chemistry
Introduction
Jean Costentin is a notable inventor based in Rouen, France. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of substituted cyclic amines. His work has implications for the treatment of nervous depression and the stimulation of vigilance.
Latest Patents
Jean Costentin holds a patent for "Substituted cyclic amines and pharmaceutical composition containing them." This invention relates to substituted arylamines and heteroarylamines, detailing their preparation process and the pharmaceutical compositions that incorporate them. The substituted amine is defined by a specific chemical formula, where R¹ and R² can form cycles with nitrogen, and R³ and R⁴ can represent various organic radicals. These compounds are particularly useful in pharmaceutical applications aimed at treating nervous depression.
Career Highlights
Throughout his career, Jean Costentin has worked with esteemed organizations, including the Centre National de la Recherche Scientifique. His research has contributed to advancements in pharmaceutical sciences, showcasing his expertise in the field.
Collaborations
Jean Costentin has collaborated with notable colleagues such as Alain Privat and Jean-Marc Kamenka. These partnerships have further enriched his research and development efforts in pharmaceutical chemistry.
Conclusion
Jean Costentin's innovative work in the field of pharmaceutical chemistry, particularly with substituted cyclic amines, highlights his role as a significant inventor. His contributions continue to influence the development of treatments for nervous depression and vigilance stimulation.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
